Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823465) titled 'RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World Study' on Sept. 11.
Study Type: Observational [Patient Registry]
Primary Sponsor: NeuroPace
Condition:
Focal Epilepsy
Drug-resistant Focal Epilepsy
Intervention:
Device: NeuroPace RNS System
Recruitment Status: Recruiting
Date of First Enrollment: September 14, 2026
Target Sample Size: 100
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07823465
Disclaimer: Curated by HT Syndication....